Skip to main content
. 2020 Nov 18;13:2959–2970. doi: 10.2147/JPR.S269370

Table 1.

Baseline Preoperative Characteristics of Patientsa

Patients (no.) 410
Age-yr. 56.8(11.6)
Male Gender-no. (%) 165(40.4)
Marital Status- no.(%)
 Never Married 34(8.5)
 Married 292(73.0)
 Living with someone 15(3.8)
 Divorced or separated 46(11.5)
 Widowed 13(3.3)
 Disability Claim Pending- no.(%) 46(11.8)
Employment Status-no.(%)
 Full-time 171(43.4)
 Part-time 36(9.1)
 Unemployed 79(20.1)
 Retired 108(27.4)
Type of Operation- no.(%)
 Thoracotomy 15(3.7)
 Total Knee Replacement 151(36.8)
 Total Hip Replacement 97(23.7)
 Mastectomy 41(10.0)
 Lumpectomy 30(7.3)
 VATS 29(7.1)
 Hand Surgery 24(5.9)
 Carpal Tunnel Surgery 5(1.2)
 Knee Arthroscopy 8(2.0)
 Shoulder Surgery 4(1.0)
 Shoulder Arthroscopy 6(1.5)
 Baseline pain at surgical site (0–10) 5(3)
 Baseline pain other than surgical site (0–10) 2(2)
Self-Perceived Likelihood of Developing Chronic Pain After Surgery- no.(%)
 Not at all 89(22.2)
 Unlikely 244(60.9)
 Somewhat likely 58(14.5)
 Very likely 10(2.5)
Self-Perceived Likelihood of Chronic Pain After Injury- no. (%)
 More Likely 68(17.1)
 Less Likely 329(82.9)
Self-Perceived Sensitivity to Pain- no. (%)
 More than average 35(8.8)
 Average 228(57.0)
 Less than average 137(34.3)
Self-Reported Unexpectedly Long Recovery Times from Past Injuries-no. (%) 64(16.0)
Past 30-Day Prescription Opioid Use- no.(%) 36(8.8)
Self-Perceived Likelihood of Addiction to Pain Medication After Surgery- no.(%)
Not at all 206(51.4)
Unlikely 172(42.9)
Somewhat likely 19(4.7)
Very likely 4(1.0)
Opioid Risk Tool Scorec 2(3)
History of Illicit Drug Use- no.(%) 46(11.2)
History of Alcohol or Drug Abuse Treatment- no.(%) 20(5.1)
Marlow-Crowne Social Desirability Scale Scored 20(6)
Barratt Impulsivity Scale Scoree 69(7)
PTSD Checklist-Civilian Version (PCL-C) Scoref 25(9)
State Anxiety Inventory Scoreg 35(11)
Trait Anxiety Inventory Scoreh 33(10)
Beck Depression Inventory-ll Scorei 10(7)
Euroqol VAS j 72(19)
Postoperative Pain Duration-daysb 79(36–230)
Postoperative Opioid Use Duration-daysb 27(9–55)

Notes: aAll values presented as mean (SD) unless otherwise noted, percentages do not include patients with missing data; bCensored patients not meeting study endpoints were excluded from calculation of these particular variables, Median (IQ Range); cScore range, 0–26, with 0–3 indicating low risk; 4–7 indicating moderate risk, and ≥ 8 indicating high risk; dScore range, 0–33, with 0–8 indicating low concern for social approval, and 20–33 indicating high concern for social approval; eScore range, 30–120, with higher scores representing greater impulsiveness; fScore range, 17–85, with increasing scores representing more self-reported posttraumatic stress disorder symptoms; gScore range, 20–80, with higher scores representing increasing state anxiety or anxiety in response to a specific situation. 395 of 410 participants (96%) completed the State Anxiety Inventory; hScore range, 20–80, with higher scores representing increasing trait anxiety or propensity to experience anxiety. 390 of 410 (95%) participants completed the Trait Anxiety Inventory; iScore range, 0–63, with 0–13 indicating minimal depression;14–19 mild depression;20–28 moderate depression; and 29–63, severe depression. 398 of 410 (97%) participants completed the Beck Depression Inventory-II; jScore range for self-assessment of health, 0–100, with 0 representing the worst imaginable health state and 100 representing the best imaginable health state.